Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Jan-24 5:13 PM View:  | Entero Therapeutics, Inc. (ENTO) | 02-Jan-24 | Grant | 19,633 | -- | -- | 3234% 0.61K to 20.24K | |
| 05-Jan-23 8:53 AM View: | Entero Therapeutics, Inc. (ENTO) | 03-Jan-23 | Grant | 84,745 | -- | -- | 19260% 0.44K to 85.19K | |
| 13-Mar-20 4:10 PM View: | Entero Therapeutics, Inc. (ENTO) | 11-Mar-20 | Grant | 29,294 | $1.45 | $42,405.70 | 29% 102.75K to 132.05K | |
| 03-Jan-20 10:00 PM View: | Entero Therapeutics, Inc. (ENTO) | 31-Dec-19 | Grant | 7,500 | $1.04 | $7,800.00 | 8% 92.5K to 100.0K | (63%) |
| 01-Oct-19 2:29 PM View: | Entero Therapeutics, Inc. (ENTO) | 30-Sep-19 | Grant | 7,500 | $0.60 | $4,500.00 | 9% 85.0K to 92.5K | (38%) |
| 02-Jul-19 6:42 PM View: | Entero Therapeutics, Inc. (ENTO) | 30-Jun-19 | Grant | 7,500 | $1.70 | $12,750.00 | 10% 77.5K to 85.0K | (78%) |
| 17-Jun-19 9:51 PM View: | Entero Therapeutics, Inc. (ENTO) | 13-Jun-19 | Grant | 30,000 | -- | -- | 39% 77.5K to 107.5K | |
| 29-Apr-19 8:22 PM View: | Entero Therapeutics, Inc. (ENTO) | 31-Mar-19 | Grant | 7,500 | $2.42 | $18,150.00 | 11% 70.0K to 77.5K | (85%) |
| 02-Jan-19 5:55 PM View: | Entero Therapeutics, Inc. (ENTO) | 28-Dec-18 | Grant | 7,500 | $1.29 | $9,675.00 | 12% 62.5K to 70.0K | (71%) |
| 01-Oct-18 7:56 PM View: | Entero Therapeutics, Inc. (ENTO) | 28-Sep-18 | Grant | 7,500 | $2.57 | $19,275.00 | 14% 55.0K to 62.5K | (86%) |
| 16-Jul-18 7:23 PM View: | Entero Therapeutics, Inc. (ENTO) | 29-Jun-18 | Grant | 7,500 | -- | -- | 16% 47.5K to 55.0K | |
| 02-Apr-18 4:18 PM View: | Entero Therapeutics, Inc. (ENTO) | 29-Mar-18 | Grant | 7,500 | $3.14 | $23,550.00 | 19% 40.0K to 47.5K | (88%) |
| 13-Feb-18 10:00 PM View: | Entero Therapeutics, Inc. (ENTO) | 20-Dec-17 | Grant | 7,500 | -- | -- | 23% 32.5K to 40.0K | |
| 23-Oct-17 5:47 PM View: | Entero Therapeutics, Inc. (ENTO) | 19-Oct-17 | Grant | 22,500 | -- | -- | 225% 10.0K to 32.5K |